Florida Senate - 2021                        COMMITTEE AMENDMENT
       Bill No. SB 700
       
       
       
       
       
       
                                Ì882802ÊÎ882802                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                  Comm: RCS            .                                
                  02/17/2021           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Health Policy (Rodriguez) recommended the
       following:
       
    1         Senate Amendment (with title amendment)
    2  
    3         Between lines 380 and 381
    4  insert:
    5         Section 11. Section 465.1893, Florida Statutes, is amended
    6  to read
    7         465.1893 Administration of long-acting antipsychotic
    8  medication by injection.—
    9         (1)(a) A pharmacist, at the direction of a physician
   10  licensed under chapter 458 or chapter 459, may administer a
   11  long-acting antipsychotic medication or an extended-release
   12  medication indicated to treat opioid use disorder, alcohol use
   13  disorder, or other substance use disorder or dependency,
   14  including, but not limited to, buprenorphine, naltrexone, or
   15  other medications that have been approved by the United States
   16  Food and Drug Administration by injection to a patient if the
   17  pharmacist:
   18         1. Is authorized by and acting within the framework of an
   19  established protocol with the prescribing physician.
   20         2. Practices at a facility that accommodates privacy for
   21  nondeltoid injections and conforms with state rules and
   22  regulations regarding the appropriate and safe disposal of
   23  medication and medical waste.
   24         3. Has completed the course required under subsection (2).
   25         (b) A separate prescription from a physician is required
   26  for each injection administered by a pharmacist under this
   27  subsection.
   28         (2)(a) A pharmacist seeking to administer a long-acting
   29  antipsychotic medication described in paragraph (1)(a) by
   30  injection must complete an 8-hour continuing education course
   31  offered by:
   32         1. A statewide professional association of physicians in
   33  this state accredited to provide educational activities
   34  designated for the American Medical Association Physician’s
   35  Recognition Award (AMA PRA) Category 1 Credit or the American
   36  Osteopathic Association (AOA) Category 1-A continuing medical
   37  education (CME) credit; and
   38         2. A statewide association of pharmacists.
   39         (b) The course may be offered in a distance learning format
   40  and must be included in the 30 hours of continuing professional
   41  pharmaceutical education required under s. 465.009(1). The
   42  course shall have a curriculum of instruction that concerns the
   43  safe and effective administration of behavioral health,
   44  addiction, and antipsychotic medications by injection,
   45  including, but not limited to, potential allergic reactions to
   46  such medications.
   47  
   48  ================= T I T L E  A M E N D M E N T ================
   49  And the title is amended as follows:
   50         Delete line 55
   51  and insert:
   52         F.S.; providing applicability; amending s. 465.1893,
   53         F.S.; providing additional long-acting medications
   54         pharmacists may administer under certain
   55         circumstances; revising requirements for a continuing
   56         education course such pharmacists must complete;
   57         amending s. 893.05,